News & Events
Check out the latest in all things Cas-CLOVER and piggyBac with their implications, applications, and advantages in the real world.
Demeetra has entered into an agreement with Japan’s RIKEN BioResource Research Center (RIKEN BRC) that broadens academic access to research ...
The new Harbor-IN format helps biopharma developers establish production cell lines using animal-origin-free transposase mRNA from the start, while maintaining ...
NorthX Biologics and Demeetra announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full ...
Demeetra today announced the renewal of Taiho Pharmaceutical's research license for its piggyBac transposase technology. The full announcement is shown ...
Demeetra AgBio has completed the full integration of Hera BioLabs, expanding Demeetra’s rights to the hyperactive Super piggyBac transposase platform ...
LEXINGTON, KY — November 11, 2025 — Demeetra AgBio announced that its flagship CleanCut GS CHO cell line has tested clean on ...
May 12–16, 2025 Hynes Convention Center | Boston, MA We’re bringing our latest innovations in gene editing and cell line ...
May 12-15, 2025 Congress Center Hamburg | Hamburg, Germany We're heading to Hamburg! Demeetra will be on site at BioProcess ...
May 5-8, 2025 San Jose Convention Center - San Jose, CA Demeetra is heading to SynBioBeta 2025, the premier Global ...
Build production-ready CHO cell lines with Demeetra
Talk to our team about CHO cell line development, or explore licensing and product access – including Super piggyBac.